Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 1
1975 1
1976 2
1977 4
1978 1
1979 1
1980 6
1981 3
1982 3
1983 5
1984 5
1985 4
1986 10
1987 8
1988 13
1989 25
1990 65
1991 76
1992 154
1993 162
1994 189
1995 180
1996 235
1997 250
1998 216
1999 251
2000 270
2001 338
2002 390
2003 452
2004 465
2005 631
2006 631
2007 686
2008 810
2009 831
2010 877
2011 983
2012 1093
2013 1290
2014 1731
2015 1974
2016 2132
2017 2312
2018 2444
2019 2665
2020 3057
2021 2892
2022 2278
2023 1903
2024 516

Text availability

Article attribute

Article type

Publication date

Search Results

31,180 results

Results by year

Filters applied: . Clear all
Page 1
Biomarkers in cancer epidemiology: an integrative approach.
Boffetta P. Boffetta P. Carcinogenesis. 2010 Jan;31(1):121-6. doi: 10.1093/carcin/bgp269. Epub 2009 Dec 3. Carcinogenesis. 2010. PMID: 19959558 Review.
There are different reasons for the increase in the use of biomarkers in cancer epidemiology which is as follows: (i) the fact that the identification of new carcinogens, characterized by complex exposure circumstances and weak effects, has become increasingl …
There are different reasons for the increase in the use of biomarkers in cancer epidemiology which is as follows: (i) t …
Epigenetic biomarkers in cancer epidemiology.
Verma M. Verma M. Methods Mol Biol. 2012;863:467-80. doi: 10.1007/978-1-61779-612-8_28. Methods Mol Biol. 2012. PMID: 22359311 Review.
In cancer epidemiology, epigenetic biomarkers offer advantages over other types of biomarkers because they are expressed against a person's genetic background and environmental exposure, and because epigenetic events occur early in cancer develo …
In cancer epidemiology, epigenetic biomarkers offer advantages over other types of biomarkers because they are e …
Molecular epidemiology and biomarkers in etiologic cancer research: the new in light of the old.
Vineis P, Perera F. Vineis P, et al. Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1954-65. doi: 10.1158/1055-9965.EPI-07-0457. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17932342 Review.
Molecular epidemiology was introduced in the study of cancer in the early 1980s, with the expectation that it would help overcome some major limitations of epidemiology and facilitate cancer prevention. ...There is a need for their systematic validatio …
Molecular epidemiology was introduced in the study of cancer in the early 1980s, with the expectation that it would help overc …
An epigenetic biomarker of aging for lifespan and healthspan.
Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, Hou L, Baccarelli AA, Stewart JD, Li Y, Whitsel EA, Wilson JG, Reiner AP, Aviv A, Lohman K, Liu Y, Ferrucci L, Horvath S. Levine ME, et al. Aging (Albany NY). 2018 Apr 18;10(4):573-591. doi: 10.18632/aging.101414. Aging (Albany NY). 2018. PMID: 29676998 Free PMC article.
Identifying reliable biomarkers of aging is a major goal in geroscience. While the first generation of epigenetic biomarkers of aging were developed using chronological age as a surrogate for biological age, we hypothesized that incorporation of composite clinical m …
Identifying reliable biomarkers of aging is a major goal in geroscience. While the first generation of epigenetic biomarkers o …
The Heterogeneity of Liver Cancer Metabolism.
Salazar J, Le A. Salazar J, et al. Adv Exp Med Biol. 2021;1311:127-136. doi: 10.1007/978-3-030-65768-0_9. Adv Exp Med Biol. 2021. PMID: 34014539 Free PMC article.
Primary liver cancer is the fourth leading cause of cancer death around the world. ...With the use of metabolomics technologies [5], the aberrant metabolism characteristics of cancer tissues can be discovered and exploited for the new biomarkers and ne …
Primary liver cancer is the fourth leading cause of cancer death around the world. ...With the use of metabolomics technologie …
Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories.
Rothman N, Stewart WF, Schulte PA. Rothman N, et al. Cancer Epidemiol Biomarkers Prev. 1995 Jun;4(4):301-11. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7655323 Review.
During the last decade, there has been increasing interest in the use of biomarkers in cancer epidemiology to enhance exposure assessment, to gain insight into disease mechanism, and to understand acquired or inherited susceptibility. To facilitate the use of …
During the last decade, there has been increasing interest in the use of biomarkers in cancer epidemiology to enhance e …
An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.
Bellizzi AM. Bellizzi AM. Adv Anat Pathol. 2020 May;27(3):114-163. doi: 10.1097/PAP.0000000000000256. Adv Anat Pathol. 2020. PMID: 32205473 Free PMC article. Review.
Immunohistochemistry represents an indispensable complement to an epidemiology and morphology-driven approach to tumor diagnosis and site of origin assignment. ...Specific topics covered in this review include (1) broad tumor classification and associated screening markers …
Immunohistochemistry represents an indispensable complement to an epidemiology and morphology-driven approach to tumor diagnosis and …
PSA and beyond: alternative prostate cancer biomarkers.
Saini S. Saini S. Cell Oncol (Dordr). 2016 Apr;39(2):97-106. doi: 10.1007/s13402-016-0268-6. Epub 2016 Jan 20. Cell Oncol (Dordr). 2016. PMID: 26790878 Free PMC article. Review.
Owing to inherent limitations of the biomarker prostate-specific antigen (PSA), intensive efforts are currently directed towards a search for alternative prostate cancer biomarkers, particularly those that can predict disease aggressiveness and drive better t …
Owing to inherent limitations of the biomarker prostate-specific antigen (PSA), intensive efforts are currently directed towards a se …
31,180 results
You have reached the last available page of results. Please see the User Guide for more information.